World Wires · story 26752 · unverified · 1 source(s)

Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of cen

Open in the desk

Coverage

What this site indexes